View Older Stories View More Recent Stories

Sep 5, 2023 08:00AM OmniAb to Participate in Two Investor Conferences in September
Sep 5, 2023 07:00AM Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D.
Sep 1, 2023 07:30AM Arrowhead Pharmaceuticals to Participate in Upcoming September 2023 Conferences
Aug 31, 2023 04:32PM Intuitive Machines (LUNR) Announces $20M Equity Investment
Aug 31, 2023 04:31PM Intuitive Machines Announces $20 Million Equity Investment
Aug 31, 2023 04:30PM DURECT Corporation Announces Presentations in Upcoming Investor Conferences
Aug 31, 2023 11:00AM Galecto to Present at Investor Conferences in September
Aug 31, 2023 08:00AM UroGen Pharma to Present at Upcoming Investor Conferences
Aug 31, 2023 07:00AM Axogen to Participate at Upcoming Investor Conferences
Aug 30, 2023 04:05PM Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Aug 30, 2023 08:20AM Clene to Present at Upcoming September Conferences
Aug 30, 2023 08:00AM APNIMED to Participate in Upcoming Investor Conferences in September
Aug 30, 2023 08:00AM Compass Therapeutics to Participate in Upcoming Investor Events
Aug 30, 2023 08:00AM Cognition Therapeutics Announces Participation in Upcoming September Conferences
Aug 30, 2023 08:00AM LifeMD to Participate in Two Investor Conferences in September
Aug 30, 2023 07:00AM EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Aug 29, 2023 08:44AM Form NPORT-P CANTOR FITZGERALD SUSTAI For: Jun 30
Aug 28, 2023 04:05PM Absci to Participate in Upcoming Investor Conferences
Aug 28, 2023 08:00AM SCYNEXIS to Participate in September Investor Conferences
Aug 28, 2023 06:34AM Cantor Starts NextGen Healthcare Inc (NXGN) at Overweight, 'attractive investment profile that is not fully reflected'
Aug 25, 2023 04:42AM Cantor Fitzgerald Upgrades Ardelyx, Inc (ARDX) to Overweight
Aug 24, 2023 06:21PM Connect Biopharma to Participate in Upcoming September Investor Conferences
Aug 24, 2023 08:00AM Alpha Tau Medical to Participate in September Investor Conferences
Aug 24, 2023 05:55AM Cybin Inc (CYBN) Renews $35M At-The-Market Equity Program
Aug 23, 2023 09:37PM Cybin Announces Renewed At-The-Market Equity Program of up to US$35 Million
Aug 23, 2023 10:54AM Form N-PX CANTOR FITZGERALD SUSTAI For: Jun 30
Aug 23, 2023 09:00AM Arcus Biosciences to Participate in Multiple Upcoming Investor Conferences
Aug 22, 2023 09:00AM Borqs Technologies Received Extension from CFIUS for HHE Divestment, and Will Consider Share Buyback and/or Pay a Special Dividend
Aug 18, 2023 03:11PM Form N-23C3A CANTOR FITZGERALD SUSTAI For: Aug 18
Aug 18, 2023 07:00AM Augmedix Announces Participation in Upcoming Investor Conferences in September 2023
Aug 17, 2023 01:25PM BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Spotlighted in New Cantor Fitzgerald Research Brief
Aug 17, 2023 08:30AM Arcturus Therapeutics to Attend Upcoming Investor Conferences
Aug 16, 2023 04:50PM Orchid Island Capital Announces August 2023 Monthly Dividend and July 31, 2023 RMBS Portfolio Characteristics
Aug 15, 2023 05:01PM Form 424B3 Cantor Fitzgerald Income
Aug 15, 2023 06:33AM Cantor Fitzgerald Starts Computer Programs and Systems (CPSI) at Overweight
Aug 14, 2023 04:07PM Alaunos Therapeutics (TCRT) to wind down its TCR-T Library Phase 1/2 trial and prioritize the hunTR platform
Aug 14, 2023 04:05PM Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
Aug 14, 2023 03:45PM Form 13F-NT CANTOR FITZGERALD INVEST For: Jun 30
Aug 14, 2023 03:45PM Form 13F-NT CANTOR FITZGERALD & CO. For: Jun 30
Aug 14, 2023 03:44PM Form 13F-NT CANTOR FITZGERALD SECURI For: Jun 30
Aug 14, 2023 03:44PM Form 13F-NT Cantor Fitzgerald Europe For: Jun 30
Aug 14, 2023 03:42PM Form 13F-HR CANTOR FITZGERALD, L. For: Jun 30
Aug 14, 2023 08:16AM The Metals Company (TMC) Announces $27 Million Registered Direct Offering at $2.00 Per Share Plus Class A Warrants
Aug 14, 2023 08:15AM The Metals Company Announces ~US$27 Million Registered Direct Offering at $2.00 Per Share Plus Class A Warrants
Aug 11, 2023 04:20PM Form 10-Q Cantor Fitzgerald Income For: Jun 30
Aug 10, 2023 04:05PM Phunware Reports Second Quarter 2023 Financial Results
Aug 10, 2023 04:05PM Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update
Aug 10, 2023 02:00PM Guanajuato Silver Closes C$8,010,000 "Bought Deal" Financing
Aug 10, 2023 07:00AM MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
Aug 10, 2023 06:45AM Susan Munson and Andrew Davidoff Join Academy Securities as Managing Directors, Rates Liquidity
View More Recent Stories View Older Stories